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INTRODUCTION
Methicillin - resistant Staphylococcus aureus
(MRSA) strains account for60% of S. aureus clini-
cal isolates in Japan, Singapore, and Taiwan, 50%
in Italy and Portugal, and 34% in the United States
(1). MRSA isolates have an additional transpepti-
dase, a 78 Kd class B penicillin -binding protein
(PBP) named PBP 2(PBP 2a), which has a de-
creased affinity to β - lactams (2 -5). PBP 2a is en-
coded by a mecA gene of unknown origin (6, 7).
Usually, susceptible strains do not have the gene of
this PBP (3). Although it is generally believed that
PBP 2a is essential for conferring broad spectrum
resistance to virtually all clinically used β - lactam
antibiotics (8 -11) in S. aureus, the β - lactam (e.g.,
methicillin) MIC for resistant strains varies widely,
from 3.1 μg to 1600 μg/ml.
Moreover, MRSA isolates with a low level of re-
sistance show a peculiar, so -called heterogeneous
expression of resistance. Our previous population
analysis study of 20 MRSA strains using oxacillin
revealed that three strains (20 -22) were hetero-
MRSA, exhibiting relatively low methicillin MICs,
ranging from 256 to 128 μg/ml, while all the others
were homo-MRSA (high- level methicillin MICs,
1024 μg/ml) (12).
It was reported (13) that transposon mutants of
MRSAs, despite the massive reductions in the mu-
tants’ methicillin MIC, retained an intact mecA and
its product, PBP 2a. The inserts were in genes in-
volved in staphylococcal cell wall synthesis (13). In
a report with heterogeneously resistant strains, cells
with increased resistance levels present at low fre-
quency (typically, 10-4 to 10-7) in the form of one or
more subpopulations, still produced normal amounts
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of PBP 2a (14).
However, there has been little study of low- and
high-resistance phenotypes of the MRSA strains to
β - lactams in relation to the organism-producing
levels of PBP 2a. Indeed, we proposed a two-step
model for the sequence of a high- level resistance
mechanism of MRSA to β - lactams (12, 15). Since
the ability to produce PBP 2a is essential for the
methicillin resistance of S. aureus, it is conceivable
that knowing the amount of PBP 2a produced by
the strains of high- and low-resistance groups
might aid in understanding PBP 2a’s role in resis-
tance to β - lactam antibiotics. In this paper, we de-
scribe a linear relationship between the protein
amount of the MRSA COL (a reference strain) and
the PBP 2a quantity by dot -blot analysis using an
antibody against PBP 2a. Moreover, since the rela-
tionship between PBP 2a amount and β - lactam
MICs has not yet been well examined in the differ-
ent clinical strains, this study aims to find out
whether or not any correlation exists.
MATERIALS AND METHODS
S. aureus strains
Clinical strains of MRSA (strains 1 -7, 9, 20 -22)
were kindly supplied by the late Dr. Toru Usui
(Kyoto Microbiological Institute, Kyoto, Japan).
Strain N315 and vancomycin (VCM) intermediate -
resistance strains (VISA) Mu3 and Mu50 were
kind gifts from Dr. Keiichi Hiramatsu (Juntendo
University, Tokyo, Japan), and strain COL was from
Dr. John J. Iandolo (University of Oklahoma Health
Sciences Center, Tulsa, OK, USA). Methicillin -
sensitive S. aureus (MSSA) ATCC 6538P was used
as a reference strain. Some properties of the clini-
cal strains used in the present study were deter-
mined previously (12).
Drug susceptibility assay of bacterial isolates
Bacterial susceptibility to antibacterial agents was
measured in vitro by employing a standard twofold
plate-dilution method using BBLTM Mueller--Hinton
II agar (Becton Dickinson, Franklin Lakes, NJ,
USA) supplemented with 25 μg/ml of Ca2+, 50 μg/
ml of Mg2+, and 2% NaCl (CA--MHA) (12). Follow-
ing overnight incubation of test strains at 37 in
MHB, cultures were diluted with 0.85% NaCl, and
then the bacteria (about 106 CFU/ml) were applied
with an inoculator onto the surfaces of 10 ml agar
layers containing the antibiotics. The plates were
incubated at 37 for 48 h and were checked for
antibacterial susceptibility. The MIC was recorded
as the lowest concentration of the antibiotic that
completely inhibited growth.
Dot-blotting for detection and quantification of
PBP 2a followed by membrane protein preparation
For the detection of PBP 2a, an antibody against
PBP 2a was prepared with a peptide of PBP 2a (16,
17) ; details of the procedure were described pre-
viously (15). The strains of MRSA were incubated
for 5 h at 37 in a BBLTM Brain Heart Infusion
(BHI) broth (Becton Dickinson). The cells were
subsequently harvested from the culture after wash-
ing three times with washing buffer (50 mM Tris-
HCl, pH 7.5, and 145 mM NaCl) by centrifugation
at 4,500g for 15 min at 6. Then the pellet was
resuspended in the same buffer, and 2.4 ml cell
suspension was treated with 24 ml of lysis buffer
containing 50 mM Tris -HCl (pH 7.5), 50 μg/ml
lysostaphin (Sigma Chemical, St. Louis, MO, USA),
10 mg/ml DNase I (Roche Diagnostics, Indianapo-
lis, IN, USA), 5 mM MgCl2, and 100 mM phenyl-
methylsulfonyl fluoride (PMSF ; Sigma Chemical)
for 1 h at 37. After centrifugation at 45,000g at
6for 1 h, the precipitant was dissolved with 10
mM phosphate buffer, pH 7.0, containing 100 mM
PMSF and diluted (1 : 25) with dilution buffer con-
taining 10 mg/ml DNase I and 200 mM MgCl2.
Crude debris were removed by centrifugation at
4,500g for 1 h at 6, and the resultant superna-
tant was centrifuged at 45,000g at 6 for 1 h.
The precipitant was suspended with 10 mM phos-
phate buffer, pH 7.0, containing 100 mM PMSF and
purified by centrifugation at 45,000g at 6for
1 h. Finally the membrane fraction was dissolved
with 50 μl of 10 mM phosphate buffer, pH 7.0. Pro-
tein concentrations were determined using a col-
orimetric method with bovine serum albumin as a
standard (15, 18). To investigate the relationship
between the PBP 2a amount and the membrane
protein fractions, 0.2 μg, 0.5 μg, 1.0 μg, and 2.0 μg
membrane fractions from MRSA COL (a reference
strain) were transferred to nitrocellulose membrane
(Bio-Rad Laboratories, Hercules, CA, USA) using
the Bio-Dot -SF Microfiltration Apparatus (Bio-
Rad) according to the manufacturer’s instructions.
PBP 2a was identified by the chemiluminescence
method as described with the ECL Plus Western
Blotting kit (Amersham Biosciences, Piscataway,
NJ, USA). Repeated experiments were done to con-
firm the results.
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To determine the PBP 2a quantities in mem-
brane fractions of different MRSA clinical strains,
1.0 μg protein was used following the procedure
described above with MSSA ATCC 6538P as a qual-
ity control strain.
Statistical analysis
To assess the correlation between PBP 2a levels
of the strains examined and the corresponding
MICs of β - lactams, the Pearson correlation coeffi-
cient was calculated by using a linear model with
terms for the two variables.
RESULTS
Antibacterial activity
All of the MRSA strains examined in the present
study were resistant to β - lactams (e.g., methicillin
MIC, 64 - 1,024 μg/ml), but strain N315 showed
a low MIC (8 μg/ml), which was close to those of
β - lactam-susceptible strains. Using a PCR tech-
nique, we confirmed that all the MRSA strains
(100%), including N315, carried the mecA gene.
Detection and quantification of PBP 2a with dot-
blot
Based on the previous result that a single band
(molecular mass, about 76 kD) was detected by
means of sodium dodecyl sulfate -polyacrylamide
gel electrophoresis of a membrane fraction of
MRSA (10 μg of protein) followed by Western blot-
ting analysis with the antibody against the peptide
of PBP 2a (15), we conducted the study on detec-
tion and quantification of PBP 2a with dot-blot. In
the present work, PBP 2a was detected in all strains
of MRSA examined, including pre -MRSA strain
N315, with MSSA ATCC 6538P as a negative con-
trol strain. For the quantification study, we first ex-
amined the relationship between the PBP 2a amount
and membrane proteins prepared from MRSA COL
by dot -blot analysis using an antibody against
PBP 2a.
As shown in Fig. 1, the relationship between PBP
2a and membrane proteins of MRSA COL was lin-
ear. Hence, using immunoblotting we determined
the PBP 2a quantities from membrane fractions
prepared from the different clinical MRSA cells,
with MSSA ATCC 6538P as a quality control strain.
The PBP 2a amounts diverged among the strains
(Fig. 2). The three heteroresistant clinical strains
(20 -22) had higher amounts than the homoresis-
tant clinical strains, except for strains 3 and 6. How-
ever, it must be pointed out that the amounts of
PBP 2a varied among the three heteroresistant
strains (20 -22) (Fig. 2). In the present work, VISA
strain Mu3 exhibited the highest levels of PBP 2a
among the examined MRSA strains (Fig. 2).
As Fig. 3 clearly demonstrates, however, the re-
sistant phenotypes of MRSA to β - lactams were un-
related to the organism-producing level of PBP 2a.
Strains N315 and 1 showed similar PBP 2a quanti-
ties, although their respective methicillin MICs
were 8 μg/ml and 1024 μg/ml. Among the ho-
moresistant strain, MRSA 6 showed the highest
value of the PBP 2a although its oxacillin and
cephapirin MICs were 128 μg/ml and 64 μg/ml
less than MICs of MRSA isolate 2 (512 μg/ml and
128 μg/ml respectively) (Fig. 3). However, the ce-
fotaxime MIC was found to be higher (1024 μg/ml)
(A)
(B)
Fig. 1. Immuno-blot analysis of PBP 2a in membrane frac-
tion prepared from MRSA COL. Cell membrane proteins of
MRSA COL were prepared, purified, and quantified as de-
scribed in Materials and Methods. (A) Western blot analysis of
different concentrations of proteins (0.2 μg, 0.5 μg, 1.0 μg, and
2.0 μg). PBP 2a was detected by the use of ECL Plus. The
result shows five independent experiments. (B) A linear rela-
tionship between the amount of PBP 2a and membrane frac-
tion of MRSA COL.
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(A) (B) (C)
Fig. 2. Amounts of PBP 2a in the cell membranes of different clinical strains of MRSA. (A) A typical demonstration of dot-blotting
analysis of PBP 2a level. The membrane fractions of 6 strains of MRSA and MSSA (1 μg of protein) were applied. MSSA ATCC 6538P
was employed as a quality control strain. The result shows five independent experiments. (B) Dot-blotting analysis of the membrane
protein prepared from MRSA COL was used for the demonstration of the PBP 2a level of the other strain shown in (A). (C) Bar dia-
gram of PBP 2a amounts of different MRSA strains obtained clinically with MSSA ATCC 6538P as a quality control strain.
(A) (B)
(C) (D)
Fig. 3. Relationship between PBP 2a levels and MIC values of oxacillin (A), methicillin (B), cephapirin (C), and or cefotaxime (D)
of 13 different strains of MRSA.
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in strain 6 than MRSA isolate of 2 (512 μg/ml).
Discrepancy was also found with heteroresistant
strain as shown in Fig. 3.
Statistical analysis
To assess the correlations between the PBP 2a
levels of the strains examined and the correspond-
ing MICs of β - lactams, we assumed a linear model
with terms for the two variables and calculated the
Pearson correlation coefficients for the drugs, with
the exception of that for methicillin. The coefficients
were -0.677 for oxacillin, -0.482 for cephapirin, and
-0.153 for cefotaxime. The corresponding probabil-
ity values (p-values, two- tailed) were 0.011, 0.095,
and 0.618, respectively. For the latter two drugs,
the results of this study suggest that there are no
linear relationships between the PBP 2a levels of
the MRSA strains examined and the drugs’ MICs.
However, in the case of oxacillin, the resulting
p-value suggests that we could not exclude a lin-
ear relationship between the PBP 2a levels and the
drug MICs.
DISCUSSION
A wide range of β - lactam MICs from the level of
MSSA to4,000 μg/ml has been reported in clini-
cal strains of MRSA, despite the fact that theseMICs
have an altered PBP 2a that β - lactam antibiotics
do not inhibit at chemotherapeutic levels (9, 10, 14,
19). In the present study, the range of β - lactam
resistance levels for MRSA also varied widely. For
example, the MICs of oxacillin and cefotaxime
were 64 μg/ml to 512 μg/ml and 32 μg/ml to 1024
μg/ml, respectively. On the basis of bacterial
susceptibility to β - lactam antibiotics, methicillin -
resistant S. aureus isolates could be classified into
low- and high-resistance groups. Again, various
phenotypic expressions of resistance (homogene-
ous or heterogeneous) have been reported in clini-
cal isolates of MRSA (12, 20, 21). This leads to the
question of whether or not PBP 2a production alone
is related to the expression of high- level methicil-
lin resistance in S. aureus. To answer this, we de-
termined the amounts of PBP 2a in different MRSA
isolates obtained clinically, following the procedure
described in Materials and Methods.
Although Araj, et al. (22) reported that the reli-
able detection of MRSA cannot be based solely on
the detection of the mecA gene in S. aureus , the
presence of clinical isolates examined in the pre-
sent study, previously classified as methicillin-
resistant, were confirmed by the PCR finding that
all of them carry the mecA gene, including strain
N315 (12, 23, 24).
In the present study, we provide clear evidence
with clinically isolated strains that there is no rela-
tionship between PBP 2a amount and β - lactam MIC
value. First, the amount of PBP 2a varied widely
among the highly and homogeneously resistant
strains 1 -7 and 9 (methicillin MIC 1024 μg/ml).
The PBP 2a quantities were higher in strains 3, 6,
and 7 than in the others. Second, strains 20-22 pro-
duced significantly high amounts of PBP 2a, yet ex-
hibited only low- level heterogeneous resistance.
Comparing strains 20 and 22, we found that, even
though the cephapirin MICs were the same (16 μg/
ml), the cellular amount of PBP 2a was much higher
in the latter than in the former.
This is supported by the statistical analysis. For
cephapirin and cefotaxime, the results of this study
suggest that there are no linear relationships be-
tween PBP 2a levels and drug MICs. Unfortunately,
in the case of oxacillin, we failed to exclude a cer-
tain correlation between the two variables. With re-
spect to oxacillin, possibly as well as methicillin,
the strains employed in this study were divided into
two groups : those having drug MICs of 512 μg/ml
( 1,024 μg/ml for methicillin) and those having
drug MICs of less than that. Overall, this appears
to fit to a significant inverse correlation between the
two variables. On the other hand, the PBP 2a
amounts of the members of both groups ranged
from low to high levels, thus demonstrating no par-
ticular relationship between the two parameters.
PBP 2a is encoded by the mecA gene, which is
regulated by two upstream genes, mecR1 and mecI
(25). They can express mecA constitutively, or they
can use the β - lactamase regulatory genes, blaR1
and blaI , to optimally express mecA , since BlaR1
is a strong inducer of mecA whereas BlaI is a weak
repressor (25 -28). One report described that the
uninduced amounts of PBP 2a from penicillinase -
producing parents were lower than those for
penicillinase -negative variants (29). In the present
study, similar results were found with β - lactamase-
nonproducing heteroresistant isolates (strains
20-22) that lack both regulatory genes mecRI/mecI
and blaRI/blaI (12). In contrast with that report,
we found that the β - lactamase-producing high-
resistance clinical isolates exhibited relatively less
PBP 2a, except for strain 1, a β - lactamase nonpro-
ducing homoresistant strain with a lower amount
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of cellular PBP 2a. However, strain 1 carried mecRI/
mecI regulatory genes, according to our previous
report (12).
The apparent noncorrelation between MIC and
the amount of PBP 2a suggests that some other,
unknown factor contributes to the increased MIC.
According to Murakami, et al. (29) the existence
of an unknown factor was suggested previously
from the observation that heterogeneously resis-
tant strains produced significant amounts of PBP 2a
under conditions in which small fractions of bac-
terial cells were resistant. In a study with trans-
poson mutants of MRSAs selected for their re-
duced resistance, the mutants retained an intact
mecA , and its product, PBP 2a, also remained unaf-
fected despite the massive reduction in the me-
thicillin MIC of the mutants (13). Biochemical analy-
sis of these mutants indicated that the inserts were
in genes involved in staphylococcal cell wall syn-
thesis (13). Ryffel, et al. (19) reported that the
high- level resistance expressed by a minority popu-
lation of methicillin -resistant staphylococci was due
to one or more chromosomal mutations (chr*) lo-
cated outside of mecA , the gene encoding PBP 2a.
One of the most probable hypotheses to explain the
mutation is that MRSA might acquire the ability to
provide PBP 2a with sufficient quantities of the pre-
cursors on the nascent cross wall of the staphylo-
coccal cell (15).
Hanaki, et al. (30) reported that Mu3 and Mu50
strains produced three to five times the amount of
PBP 2a than VCM-susceptible S. aureus strains with
or without methicillin resistance. In our study,
VISA strain Mu3 exhibited the highest levels of
PBP 2a among the 14 strains examined (Fig. 2).
VCM exerts its bactericidal effect by binding to D-
alanyl -D - alanine (D-Ala -D-Ala) residues of pepti-
doglycan and its precursor units, inhibiting cell
wall peptidoglycan synthesis (31). It is commonly
accepted that cell wall thickening is responsible
for the VCM resistance of VCM-intermediate S.
aureus (VISA) strains (24, 32). Cui, et al. (31) re-
ported a strong positive correlation between VCM
and reduced susceptibilities of VISA to daptomy-
cin, and that this correlation is related to cell wall
thickening and slower growth rates in comparison
to VCM-susceptible S. aureus.
In MRSA, the incorporation of the peptidogly-
can precursor into the growing peptidolgycan chain
in the presence of a β - lactam is carried out by co-
operation between the transpeptidase activity of PBP
2a (mecA) and the transglycosylase activity of PBP
2 (pbp2) (7, 33). The β - lactam ring mimics the D-
Ala -D-Ala moiety of the normal peptidoglycan pre-
cursors. PBP 2a has low affinity for the β - lactam
ring of β - lactams (34). Thus, PBP 2a might have
low affinity for D-Ala -D-Ala in the stem peptide of
the precursor, suggesting that the protein would
require substantial amounts of the precursor for
proper functioning as a transpeptidase. Therefore,
although PBP 2a is a key protein in MRSA, not
only PBP 2a production but also the acquisition of
other factors, such as an increased ability to supply
the precursor, would be required to mediate β -
lactam resistance in MRSA.
In conclusion, there is no direct relationship be-
tween the amounts of PBP 2a expressed in MRSAs
obtained clinically and MIC values of β - lactam.
This finding is in good accord with the previously
proposed two-step model for the development of
high- level resistance to β - lactams in MRSA (12,
15, 35).
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